Nutex Health (NASDAQ:NUTX) Shares Climb 6.9% – Should You Buy?

Shares of Nutex Health Inc. (NASDAQ:NUTX) rose 6.9% on Monday. The company traded as high as $215.32 and last traded at $224.0050. 20,562 shares traded hands during trading, a decline of 88% from the average session volume of 166,768 shares. The stock had previously closed at $209.59.

Analyst Upgrades and Downgrades

Several research firms have commented on NUTX. LADENBURG THALM/SH SH started coverage on Nutex Health in a research report on Monday. They issued a “buy” rating and a $336.00 target price for the company. Lake Street Capital restated a “buy” rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, October 3rd. B. Riley Financial reaffirmed a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. Finally, Zacks Research lowered shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, Nutex Health has an average rating of “Moderate Buy” and an average target price of $323.67.

Nutex Health Stock Performance

The stock has a 50 day moving average of $201.41 and a 200 day moving average of $163.35. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of 8.33 and a beta of 0.55.

Nutex Health (NASDAQ:NUTX) last announced its earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating the consensus estimate of $4.95 by $4.43. The business had revenue of $210.75 million for the quarter, compared to analysts’ expectations of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. As a group, analysts predict that Nutex Health Inc. will post 27.58 EPS for the current year.

Insider Activity

In other news, Director Scott Saunders sold 203 shares of the business’s stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the transaction, the director owned 400 shares in the company, valued at approximately $85,700. The trade was a 33.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 44.68% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

Large investors have recently modified their holdings of the company. Corient Private Wealth LP bought a new position in Nutex Health during the second quarter worth $1,142,000. Quantinno Capital Management LP acquired a new position in Nutex Health in the first quarter valued at $843,000. Empowered Funds LLC acquired a new position in Nutex Health in the second quarter valued at $7,720,000. First Trust Advisors LP boosted its position in Nutex Health by 60.0% during the first quarter. First Trust Advisors LP now owns 18,335 shares of the company’s stock valued at $1,743,000 after acquiring an additional 6,874 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in Nutex Health during the second quarter valued at $3,956,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.